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The cause or causes of hypercalcemia and
hypercalcuria in sarcoidosis are obscure. Harrell
and Fisher (1) were the first to emphasize that
hypercalcemia, hyperproteinemia and elevated
serum alkaline phosphatase could occur in this
disease. Dent etat (2) believed that bone destruc-
tion represented the cause of hypercalcemia.
Anderson et at (3) concluded from their studies
that increased calcium absorption was the cause
of hypercalcemia in sarcoidosis.
Recently, Henneman et at (4) further explored
the possible mechanisms in the causation of
sarcoid hypercalcemia and, based on four com-
plete calcium balance studies on three patients
with sarcoidosis they were able to demonstrate
that the hypercalcuria in this disease appeared to
be due to endogenous hypervitaminosis D. The
abnormalities of calcium metabolism in these
subjects appeared to embrace three actions of
Vitamin D: (1) increased calcium absorption
from the intestine (decreased fecal calcium ex-
cretion), (2) parathyroid hormone-like action
and (3) increased absorption of nitrogen, sodium,
potassium, magnesium and iron. These workers
also studied the effects of cortisone and sodium
phytate, a calcium immobilizing agent, upon
their subjects and noted that both of these sub-
stances decreased urinary calcium excretion and
increased fecal calcium excretion. Terepka et at
(5), using controlled technics for the determina-
tion of ultraffiterable calcium in human serum,
noted that in Boeck's sarcoid the concentration
of ultrafilterable calcium was distinctly elevated
while the percentage of the total serum calcium
which was ultrafilterable (ratio of ultrafilterable
to total serum calcium) was normal or only
slightly elevated. They postulated that the
alteration in the concentration of ultrafilterable
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calcium pointed to a disturbance in the bone :ex-
tracellular fluid calcium equilibrium.
We herewith report an experimental study of
the effects of a potent intravenous chelating
agent, Edathamil Disodium' (Na 2-EDTA, di-
sodium ethylenediamine tetracetic acid), which
under certain conditions effectively binds largely
calcium and other divalent oligometals (Mg,
Mn, Cu, Zn, Fe), upon the cutaneous
lesions and histopathologic aberrations in three
cases of sarcoidosis. The historic, pharmacologic,
chemical and biochemical aspects of this syn-
thetic polyamine, polycarboxilic acid and related
salts have recently been reviewed by Rukavina
et at (6) and Price et at (7) in this journal.
Case 1. S. N., University Hospitals number
914762, a white female patient, 34 years of age,
was admitted to the Dermatologic Service Novem-
ber 1, 1957 for study and treatment of sarcoidosis.
According to the patient, reddish-brown, round,
painless and non-ulcerative lesions were noted on
the lower extremities approximately 10 months
before. With the exception of moderate dyspnea on
exertion, noted for two months, the patient stated
she was in good health. Alleged "healed tubercu-
losis" of the lung had been demonstrated in 1953.
Roentgen-ray studies of the chest then revealed
a calcified pulmonary lesion; a "positive" Man-
toux reaction was likewise described. Family
history revealed that the patient's grandfather
had died of "pulmonary tuberculosis".
The patient was initially studied in the Uni-
versity Hospitals' Medical Clinic in June, 1957.
Pertinent physical findings then were reddish-
brown, annular plaques of the anterior lower ex-
tremities, epitrochlear lymphadenopathy and
moderate hepatomegaly. Routine blood studies,
urinalysis, erythrocyte sedimentation rate, serol-
ogy and total serum proteins were normal. An
x-ray of the chest demonstrated questionable
evidence of hilar lymph node enlargement. Histo-
pathologic study of a pretibial lesion was com-
patible with the diagnosis of sarcoidosis.
Laboratory data in November 1957: hemoglobin
was 15.9 gms. The white blood count was 6,250
1 Edathamil Disodium was kindly furnished by
Doctor Rodney Gwinn of the Abbott Research
Laboratories, North Chicago, Illinois.
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with essentially normal differential count. The
urinalysis was normal. Serology was normal.
Non-protein nitrogen was 29 mgs. per cent. The
fasting blood sugar was 82 mgs. per cent. The
bleeding time, coagulation time, platelet count
and prothrombin time were normal. Total serum
proteins were 7.0 gms. (albumin 3.8 gms. and
globulin 3.2 gms.). Liver function studies re-
vealed the following values: cephalin flocculation
1+, thymol turbidity 3.0 units and total serum
bilirubin of 0.7 mg. (direct 0.2 mg.). Blood uric
acid was 3.1 mg. per cent. The C-reactive protein
was reported as being zero. Electrolyte studies
(sodium, potassium, calcium, phosphorous), were
normal. Twenty-four hour urinary excretion of
copper and zinc was 0.3 mg. and .19 mg/L, re-
spectively. Peripheral blood study for L.E. cells
was negative. X-ray study of the chest showed
calcification in the left upper lung field; the priorly
described "hilar adenopathy" was now believed
to be vascular rather than nodal in composition.
The electrocardiogram revealed a first degree
atrioventricular block, bigeminy and non-specific
ST and T wave changes. Roentgenograms of the
hands were normal. The Mantoux test (1:1000) was
positive. A second biopsy of a pretibial nodule
revealed again changes compatible with sarcoido-
sis. A von Kossa stain for calcium was negative.
The patient was confined in a non-metabolic
hospital unit. She was placed on a regular hospital
diet, calcium balance studies were not done.
Therapy consisted of 3 gms. of Edathamil Diso-
dium (Na 2-EDTA) given intravenously daily
over a 4-hour period for 15 consecutive days (45
gms. total). Concomitant medication consisted
of pyridoxine 75 mg. daily. At no time during the
course of therapy did the patient experience any
untoward effects. Pre-treatment laboratory
studies were repeated with the following changes
noted: electrocardiograms showed the disappear-
ance of bigeminy, a negative Mantoux reaction
(1:1000), increased urinary zinc excretion (3.0
mg/L), and histopathologic changes suggested a
reduction in epithelioid cells and lymphocytes.
The clinical changes in the cutaneous lesions were
striking: flattening of the plaques of the lower
extremities was apparent by the third day of
therapy and by the tenth day only a very slightly
infiltrated erythematous stain remained at the
site of the previous lesions. The patient was dis-
charged on a dosage of pyridoxine (75 mg. a day).
She was next seen in the outpatient clinic two
months later with no unusual complaints. Post-
treatment cutaneous improvement was main-
tained. Routine blood and urine studies and x-ray
of the chest were essentially unchanged. However,
the Mantoux test, which during therapy had
become negative was strongly positive at a
1:10,000 dilution.
Case L A. K., University Hospital number
916896, a white female patient, 55 years of age,
was admitted to the Dermatologic Service of the
University of Minnesota Hospitals November 11,
1957 for study and treatment of sarcoidosis.
Cutaneous changes on the left leg were first noted
by the patient three years before and similar
round, painless lesions involving the skin of her
right elbow were noted 13 years prior to her
hospitalization. Shortly prior to confinement on
the Medical service (August, 1957), she had noted
the appearance of additional cutaneous changes
involving her left arm and face. Concomitantly,
there was weakness, fatigue and slight exertional
dyspnea. Pertinent physical findings on that
hospital admission, consisted of a 4 x 4 cm. brown-
red, annular, infiltrated lesion of the right fore-
arm and smaller brown nodules of the left pre-
tihial region, left forearm and lateral to the right
orbit. The lungs were clear to auscultation and
percussion. No cardiomegaly was noted. The
supraclavicular lymph nodes were palpable as
was the tip of the spleen. Pertinent laboratory
data follows: erythrocyte sedimentation rate of
38 mm/hour, total serum protein of 8 gms. per
cent (3.4 gins, albumin and 4.6 gms. globulin),
confluent densities of the lungs by x-ray, histo-
pathologic data (left arm, right arm, left leg, and
right scalene node) compatible with a diagnosis of
sarcoidosis and a negative Mantoux reaction. The
diagnosis was sarcoidosis involving the skin,
lungs, spleen, and scalene lymph nodes.
She was re-admitted to the University of Min-
nesota Hospitals on the Dermatologic Service
November 11, 1957. History and physical findings
were essentially unchanged. Laboratory data:
Hemoglobin 13.0 gms. The white blood count was
6,700 with 7% monocytes noted in the differential
count. The nonprotein nitrogen was 21 mg. per
cent. The fasting blood sugar was 87 mg. per cent.
The bleeding time, coagulation time, platelet
count and prothrombin time were normal. Total
serum proteins were 7.4 gms. (albumin 3.3 gins.
and globulin 4.1 gms.). Liver function studies re-
vealed the following values: cephalin flocculation
1+, thymol turbidity 3 units and total serum
bilirubin of 0.7 mgs. (direct 0.1 mg.). Blood uric
acid was 4.1 mg. per cent. The C-reactive protein
was reported as zero. Electrolyte studies (sodium,
potassium, calcium, phosphorus) were normal.
Twenty-four hour urinary excretion of copper
and zinc was 0.52 and 0.01 mg/L respectively.
Peripheral blood studies for L. E. cells were
negative. X-ray of the chest was unchanged.
Roentgenograms of the hands were normal. The
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electrocardiogram was normal. The Mantoux
(1:1000) was negative. Histopathologic study of
tissue secured from a right elbow lesion revealed
changes compatible with sarcoidosis. The von
Kossa stain for calcium was negative.
The confinement, dietary, experimental pro-
grams and therapy were similar to those of Case 1.
At no time did the patient experience any unto-
ward effects. All pre-treatment laboratory tests
were repeated during the course of treatment and
the following changes noted: transient leukopenia
and albuminuria, a moderate clearing of the
densities in the right lung apex by x-ray, histo-
pathologic skin changes consisting of a decrease
in epithelioid elements, giant cells, and lympho-
cytes, and a marked increase in urinary zinc ex-
cretion (6.7 mg/L). The patient was discharged
taking pyridoxine (75 mgs. a day). The patient
was seen two months later having no unusual com-
plaints. Routine blood and urine studies and chest
x-ray were essentially unchanged. The cutaneous
lesions were progressively less infiltrated.
Case S. C. B., University Hospital number
923440, a white female patient, 55 years of age,
was admitted to the Dermatologic Service of the
University of Minnesota Hospitals, January 27,
1958, for study and treatment of sarcoidosis. Ac-
cording to the patient her illness began approxi-
mately ten years prior to admission with progres-
sively enlarging discoloration involving the back,
nose and left arm. Concomitantly, there was
noted severe pain at the angles of the jaws upon
taking food or fluids. She had likewise complained
of persistent cough, sore throat and nasal dis-
charge since a "nose operation" in 1944. Con-
tinual "tearing of the eyes" bilaterally and "mild
high blood pressure" were of recent origin. The
patient had been seen by Dr. Henry B. Michelson
in 1955 with a histopathologic diagnosis of sar-
coidosis confirming the clinical impression. Dr.
Michelson referred this patient for study and
therapy. Pertinent physical findings consisted of
obesity, borderline hypertension (150/90), granu-
lar pharyngitis, symmetrical enlargement of the
submaxillary glands and cutaneous changes
characterized by a diffuse reddish-brown plaque
over the cartilagenous portion of the nose, a
similar plaque on the left arm and a 5 x 6 cm. arci-
form infiltrated plaque of the posterior chest.
Consultation confirmed the presence of severe
atrophic rhinitis, pharyngitis sicca and an atypi-
cal temporo-mandibular joint syndrome. The
excessive lacrimation was believed to be secondary
to the rhinitis. None of these findings was held
as being due to sarcoidal involvement.
Laboratory data. Hemoglobin was 14.9 gms. The
white blood count was 4.750 with a normal dif-
ferential count. The urinalysis was normal. The
serology was normal. The non-protein nitrogen
was 23 mgs. per cent. The fasting blood sugar was
86 mgs. per cent. The bleeding time, coagulation
time, platelet count and prothrombin time were
normal. Total serum proteins were 7.0 gms. per
cent (3.8 gms. albumin and 3.2 gms. globulin).
Liver function studies revealed the following
values: cephalin flocculation 1+, thymol turbidity
2.0 units and total serum bilirubin 0.6 mgs. (direct
0.1 mgs.). Blood uric acid was 5.0 mgs. per cent.
The C-reactive protein was reported as being
zero. Electrolyte studies (sodium, potassium,
calcium, phosphorus) were normal. Twenty-four
hour urinary excretion of copper and zinc was
0.02 and 1.26 mgs/L respectively. Peripheral
blood studies for L. E. cells were negative. Roent-
genograms of the chest revealed slight hilar
prominence and a bilateral nodular infiltrate in
the upper lobes. X-rays of the gastrointestinal
tract and hands were normal. The electrocardio-
gram was normal. The Mantoux test (1:1000) was
normal. Histopathologic study of the lesiou of the
back was consistent with the diagnosis of sar-
coidosis. Von Kossa stain for tissue calcium was
negative.
The conditions of study and therapy were those
of cases 1 and 2. The patient developed laryngo-
tracheal bronchitis which responded to penicillin
therapy. Recurrent epistaxis was attributed to
the atrophic rhinitis (hemostatic mechanism tests
were consistently normal). All pre -treatment
laboratory tests were repeated with the following
changes noted: transient leukopenia and albumi-
nuria, questionable x-ray pulmonary changes and
little change in the post-treatment cutaneous
biopsy specimen. There was definite flattening of
all cutaneous lesions with a color change from red-
dish-brown to tan. Islands of normal appearing
skin appeared throughout the lesion of the upper
back. There was reduction in size of the subman-
dibular glands, and the excessive lacrimation
and pain were alleviated. The patient was dis-
charged from the hospital on pharmacologic doses
of pyridoxine (75 mgs. a day).
SUMMARY
Three patients with proven cutaneous and
suggestive visceral sarcoidosis have been treated
experimentally with a potent oligometal binding
agent (Na 2-EDTA). The rationale for this
therapeutic approach to sarcoidosis has been
outlined. There was clinical and histologic evi-
dence of improvement in all cases studied.
Further experimental studies with this new them-
peutic agent are in progress.
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